نتایج جستجو برای: febrile neutropenia drug

تعداد نتایج: 606432  

2012
Bhavik D. Doshi Nilesh M. Pandya Chirag A. Shah Ashish K. Gupta Mehul V. Makwana

The present study was aimed to evaluate the incidences of chemotherapy-induced neutropenia and febrile neutropenia in the patients with solid tumors in India. The patients with carcinomas of breast, lung, ovary, colon, head and neck, and liver were divided in two groups. Group 1 was for the patients who experienced grade 0-2 neutropenia and Group 2 was for the patients with grade 3-4 neutropeni...

Journal: :Clinical Microbiology and Infection 2017

Journal: :memo - Magazine of European Medical Oncology 2012

Journal: :Annals of Oncology 2014

Journal: :The European respiratory journal 1996
T Urban M P Schuller B Lebeau

Myelosuppression is the major dose-limiting toxicity of chemotherapy in small cell lung cancer (SCLC). The capacity of colony stimulating factors (CSFs) to stimulate granular neutrophil recovery may be of great value to prevent or cure febrile neutropenia and to increase dose-intensity. The aim of this review was to assess the current use of CSFs in SCLC on the basis of experimental and clinica...

2010
Brunna E Alves Silmara AL Montalvao Franciso JP Aranha Tania FG Siegl Carmino A Souza Irene Lorand-Metze Joyce M Annichino-Bizzacchi Erich V De Paula

BACKGROUND Febrile neutropenia carries a high risk of sepsis complications, and the identification of biomarkers capable to identify high risk patients is a great challenge. Angiopoietins (Ang -) are cytokines involved in the control microvascular permeability. It is accepted that Ang-1 expression maintains endothelial barrier integrity, and that Ang-2 acts as an antagonizing cytokine with barr...

Journal: :The Brazilian Journal of Infectious Diseases 2014

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید